1[1]Teufelsbauer H, Proidl S, Havel M, et al. Early activation of hemostasis during cardiopulminary bypass: evidence for thrombin mediated hyperfibrinolysis. Thromb Haemost, 1992, 68(3): 250-252.
2[2]Dayal S, Pati HP, Sharna MP, et al. Tissue plasminogen activator and plasminogen activator inhibitor status in Budd-Chiari syndrome.Haemostasis, 1996, 26 (5): 284-287.
3[3]Huber K, Kirchheimer JC, Koringer C, et al. Hepatic synthesis and clearance of components of the fibrinolytic system in healthy volunteersand in patients with different stages of liver cirrhosis. Throm Res,1991,62: 491-500.
4[6]Ben AZ, Panagou M, Patch D, et al. Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography. J Hepatol, 1997, 26(3): 554-559.
5[7]Sehetz MR. Coagulation disorders in acute renal failure. Kidney Int Suppl, 1998, 66: 96-101.
6[8]Okajima K. Clinical revelevance of determination of plasma AT Ⅲ and α2 antiplasmin activities in patients with DIC application of the molecularmarkers for the analysis of pathophysiology of DIC. Rinsho Byori,1994, 42 (1): 45-55.
7[9]Rocha E, Paramo JA, Montes R, et al. Acute generalized, widespread bleeding. Diagnosis and management. Haematologica, 1998, 83 ( 11 ):1024-1037.
